Related Experiment Video
Updated: Jul 29, 2025

12:20
Use of the Operant Orofacial Pain Assessment Device OPAD to Measure Changes in Nociceptive Behavior
Published on: June 10, 2013
21.2K
Reducing Opioid Use for Chronic Pain With a Group-Based Intervention: A Randomized Clinical Trial
Harbinder K Sandhu1, Katie Booth1, Andrea D Furlan2,3,4
1Warwick Clinical Trials Unit, Warwick Medical School, University of Warwick, Coventry, United Kingdom.
JAMA
|May 23, 2023
Summary
A group-based self-management intervention significantly reduced opioid use in chronic nonmalignant pain patients. However, it did not improve pain interference with daily life activities compared to usual care.
Area of Science:
- Pain Management
- Opioid Use Disorder
- Behavioral Medicine
Background:
- Opioid use for chronic nonmalignant pain poses significant risks.
- Effective strategies are needed to reduce opioid dependence and improve patient outcomes.
Purpose of the Study:
- To evaluate a multicomponent, group-based, self-management intervention for reducing opioid use in chronic nonmalignant pain.
- To assess the intervention's impact on pain-related disability.
Main Methods:
- A multicentered randomized clinical trial involving 608 adults on strong opioids for chronic nonmalignant pain.
- Participants received either usual care or a 12-month intervention including group sessions, skill-based learning, and 1-on-1 support.
- Primary outcomes included opioid discontinuation rates and Patient-Reported Outcomes Measurement Information System Pain Interference scores.
Main Results:
- The intervention group showed a significantly higher rate of opioid discontinuation at 12 months (29% vs. 7%).
- No statistically significant difference was observed in pain interference scores between the intervention and usual care groups.
- Serious adverse events were slightly higher in the intervention group, with some participants experiencing opioid withdrawal symptoms.
Conclusions:
- A group-based educational intervention significantly reduced patient-reported opioid use in chronic nonmalignant pain.
- The intervention did not improve perceived pain interference with daily life activities.
- Further research may be needed to optimize interventions for both opioid reduction and functional improvement.
Related Concept Videos
Analgesia and Pain Management
676
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
676
Opioid Analgesics: Synthetic and Semisynthetic Opioids
353
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
353
Opioid Analgesics: Morphine and Other Natural Cogeners
306
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
306

